GANX - Gain Therapeutics, Inc.
1.94
-0.085 -4.381%
Share volume: 94,601
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$2.02
-0.08
-0.04%
Summary score
36%
Profitability
43%
Dept financing
11%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-26.24%
Return on assets
-21.76%
Return on sales
-13909.73%
Return on invested capital
248.43%
Total debt ratio
26.02%
Debt ratio change over timeo
-0.87%
Current Ratio
7.26%
Quick Ratio
8.71%
Cash Position Ratio
6.92%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-32.57%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
39.19%
Debt ratio change over timeo
-0.64%
Current Ratio
2.89%
Quick Ratio
0%
Cash Position Ratio
2.5%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-27.35%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
39.46%
Debt ratio change over time
0%
Current Ratio
2.97%
Quick Ratio
0%
Cash Position Ratio
2.66%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-114.31%
Return on assets
-110.61%
Return on sales
-4067.63%
Return on invested capital
-106.29%
Total debt ratio
-86.89%
Debt ratio change over time
-0.87%
Current Ratio
2.62%
Quick Ratio
2.72%
Cash Position Ratio
2.44%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GANX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -26.24% | 14.82% | 9.25% | 0% |
| Return on assets | -21.76% | 4.21% | 3.01% | 0% |
| Return on sales | -13909.73% | 27.61% | 25.13% | 0% |
| Return on invested capital | 248.43% | 8.25% | 9.21% | 0% |
| Profitability | 25% | 76% | 57% | 0% |
| Total debt ratio | 26.02% | 81.46% | 59.72% | 0% |
| Debt ratio change over time | -0.87% | -9.8% | -49.67% | 0% |
| Dept financing | 8% | 25% | 18% | 25% |
| Current Ratio | 2.89% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 2.5% | 0.13% | 0.46% | 0% |
| Liquididy | 75% | 7% | 9% | 0% |
| Short-term ratios | GANX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -32.57% | 4.34% | 2.26% | 0% |
| Return on sales | 0% | 28.22% | 23.48% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 0% |
| Total debt ratio | 39.19% | 81.06% | 60.18% | 0% |
| Debt ratio change over time | -0.64% | 0% | 0% | 0% |
| Dept financing | 12% | 25% | 44% | 0% |
| Current Ratio | 2.89% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 2.5% | 0.13% | 0.46% | 0% |
| Liquididy | 50% | 37% | 37% | 0% |
